CFO Jennifer Gerold Resigns Effective November 17, 2026
CRMZ is trading near its 52-week low of $1.98 (6.1% above the low).
Summary
CFO Jennifer Gerold resigned for personal reasons effective November 17, 2026. She will stay through the transition while the company searches for a replacement.
Key Events · Executive and Board Changes · CRMZ
-
CFO Resignation
Jennifer Gerold resigned as CFO effective November 17, 2026, citing personal considerations. The company stated the decision did not result from any disagreement on operations, policies, or practices.
-
Transition Period
Ms. Gerold will continue in her current role until November 17, 2026 to ensure an orderly transition while the company searches for a replacement.
-
Governance Context
The departure follows the August 2026 disclosure of a material weakness in tax-related internal controls and restatements of 2024, 2025, and Q1 2026 financials, as well as a Q2 2026 net loss of $474,789.
-
Next Milestone
The company is actively searching for a new CFO; no successor has been named as of the filing date.
Analysis · CRMZ · Trade & Services
CreditRiskMonitor's CFO is leaving just weeks after the company disclosed a material weakness in tax-related internal controls and restated three periods of financials. The departure is framed as personal and not due to any disagreement, but the timing — amid an ongoing restatement and a Q2 net loss — makes the CFO transition a key governance event for a micro-cap company already under financial-reporting scrutiny.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRMZ was trading at $2.10 on OTC in the Trade & Services sector, with a market capitalization of approximately $22.6M. The 52-week trading range was $1.98 to $2.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.